Complete Genomics, Inc. Files Registration Statement for Proposed Offering of Common Stock

MOUNTAIN VIEW, Calif., May 10, 2011 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM) today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the underwritten public offering of 4,500,000 shares of its common stock, or up to 5,175,000 shares if the underwriters exercise their over-allotment option. The shares of common stock to be sold in this offering are proposed to be sold solely by Complete Genomics, Inc.